Shantell Laketa Heiber

Array ( [id] => 3928617 [patent_doc_number] => 05939073 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-17 [patent_title] => 'Fish pancreatic disease virus' [patent_app_type] => 1 [patent_app_number] => 8/544681 [patent_app_country] => US [patent_app_date] => 1995-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 9155 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/939/05939073.pdf [firstpage_image] =>[orig_patent_app_number] => 544681 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3872916 [patent_doc_number] => 05804192 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-08 [patent_title] => 'Process for obtaining procyanidol oligomers from plants by extractions' [patent_app_type] => 1 [patent_app_number] => 8/539463 [patent_app_country] => US [patent_app_date] => 1995-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2015 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/804/05804192.pdf [firstpage_image] =>[orig_patent_app_number] => 539463 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3648946 [patent_doc_number] => 05605827 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-25 [patent_title] => 'Infectious bursal disease virus VP2 fusion protein expressed by baculovirus' [patent_app_type] => 1 [patent_app_number] => 8/538844 [patent_app_country] => US [patent_app_date] => 1995-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5271 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/605/05605827.pdf [firstpage_image] =>[orig_patent_app_number] => 538844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3933647 [patent_doc_number] => 05871742 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-16 [patent_title] => 'Recombinant Avipox virus encoding polypeptide of mycoplasma gallisepticum, and utilized a live vaccine' [patent_app_type] => 1 [patent_app_number] => 8/525742 [patent_app_country] => US [patent_app_date] => 1995-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 16559 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/871/05871742.pdf [firstpage_image] =>[orig_patent_app_number] => 525742 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4177571 [patent_doc_number] => 06149918 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-21 [patent_title] => 'Human herpesvirus type 8 isolated from human lymphoma cell line' [patent_app_type] => 1 [patent_app_number] => 8/529881 [patent_app_country] => US [patent_app_date] => 1995-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9264 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/149/06149918.pdf [firstpage_image] =>[orig_patent_app_number] => 529881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4210203 [patent_doc_number] => 06086899 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-11 [patent_title] => 'Vaccine adjuvant and vaccine' [patent_app_type] => 1 [patent_app_number] => 8/513162 [patent_app_country] => US [patent_app_date] => 1995-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 13992 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/086/06086899.pdf [firstpage_image] =>[orig_patent_app_number] => 513162 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4129415 [patent_doc_number] => 06120989 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-19 [patent_title] => 'Isolated human cytomegalovirus polypeptides and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/506553 [patent_app_country] => US [patent_app_date] => 1995-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 23 [patent_no_of_words] => 16340 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/120/06120989.pdf [firstpage_image] =>[orig_patent_app_number] => 506553 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3623113 [patent_doc_number] => 05686076 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-11 [patent_title] => 'gD-negative bovine herpesvirus mutant, capable of direct cell-to-cell transmission' [patent_app_type] => 1 [patent_app_number] => 8/503781 [patent_app_country] => US [patent_app_date] => 1995-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 8 [patent_no_of_words] => 5163 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/686/05686076.pdf [firstpage_image] =>[orig_patent_app_number] => 503781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1222857 [patent_doc_number] => 06699475 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-02 [patent_title] => 'Recombinant pox virus for immunization against tumor-associated antigens' [patent_app_type] => B1 [patent_app_number] => 08/481804 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 7793 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/699/06699475.pdf [firstpage_image] =>[orig_patent_app_number] => 08481804 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3943899 [patent_doc_number] => 05955088 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-21 [patent_title] => 'Pharmaceutical compsition of herpes simplex virus type-1 (HSV-1), glycoproteins' [patent_app_type] => 1 [patent_app_number] => 8/482105 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 15898 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/955/05955088.pdf [firstpage_image] =>[orig_patent_app_number] => 482105 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4296784 [patent_doc_number] => 06251403 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-26 [patent_title] => 'Recombinant swinepox virus' [patent_app_type] => 1 [patent_app_number] => 8/488237 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 114 [patent_figures_cnt] => 114 [patent_no_of_words] => 86175 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/251/06251403.pdf [firstpage_image] =>[orig_patent_app_number] => 488237 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3780444 [patent_doc_number] => 05821048 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-13 [patent_title] => 'Methods, kits, and compositions for diagnosing papillomavirus infection' [patent_app_type] => 1 [patent_app_number] => 8/472666 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11565 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/821/05821048.pdf [firstpage_image] =>[orig_patent_app_number] => 472666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4129289 [patent_doc_number] => 06033904 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-07 [patent_title] => 'Recombinant swinepox virus' [patent_app_type] => 1 [patent_app_number] => 8/480640 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 114 [patent_figures_cnt] => 114 [patent_no_of_words] => 85336 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/033/06033904.pdf [firstpage_image] =>[orig_patent_app_number] => 480640 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3753984 [patent_doc_number] => 05843456 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-01 [patent_title] => 'Alvac poxvirus-rabies compositions and combination compositions and uses' [patent_app_type] => 1 [patent_app_number] => 8/486969 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 15 [patent_no_of_words] => 62944 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/843/05843456.pdf [firstpage_image] =>[orig_patent_app_number] => 486969 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3803092 [patent_doc_number] => 05830688 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'DNA sequences, vectors, recombinant viruses and method which employs recombinant vaccinia viruses capable of muliplying in CHO cells' [patent_app_type] => 1 [patent_app_number] => 8/478092 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 4950 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/830/05830688.pdf [firstpage_image] =>[orig_patent_app_number] => 478092 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3768335 [patent_doc_number] => 05756284 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-26 [patent_title] => 'Self-assembling recombinant papillomavirus capsid proteins' [patent_app_type] => 1 [patent_app_number] => 8/472672 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8856 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/756/05756284.pdf [firstpage_image] =>[orig_patent_app_number] => 472672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3693091 [patent_doc_number] => 05676950 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-14 [patent_title] => 'Enterically administered recombinant poxvirus vaccines' [patent_app_type] => 1 [patent_app_number] => 8/485229 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9259 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/676/05676950.pdf [firstpage_image] =>[orig_patent_app_number] => 485229 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4288839 [patent_doc_number] => 06183750 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-06 [patent_title] => 'Avipox virus containing DNA sequences encoding herpesvirus glycoproteins' [patent_app_type] => 1 [patent_app_number] => 8/476500 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 83 [patent_figures_cnt] => 89 [patent_no_of_words] => 34520 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/183/06183750.pdf [firstpage_image] =>[orig_patent_app_number] => 476500 [rel_patent_id] =>[rel_patent_doc_number] =>)